Literature DB >> 29345092

Known unknowns: Examining the burden of neurocognitive impairment in the end-stage renal failure population.

Scott Wilson1,2,3, Arup Dhar1,2, Peter Tregaskis1, Gavin Lambert4, David Barton1,2,3, Rowan Walker1,2.   

Abstract

The burden of neurocognitive impairment (NCI) in patients receiving maintenance dialysis represents a spectrum of deficits across multiple cognitive domains that are associated with hospitalization, reduced quality-of-life, mortality and forced decision-making around dialysis withdrawal. Point prevalence data suggest that dialysis patients manifest NCI at rates 3- to 5-fold higher than the general population, with executive function the most commonly affected cognitive domain. The unique physiology of the renal failure state and maintenance dialysis appears to drive an excess of vascular dementia subtype compared to the general population where classical Alzheimer's disease predominates. Despite the absence of evidence-based cost-effective therapies for NCI, detecting it in this population creates opportunity to proactively personalize care through education, supported decision making and targeted communication strategies to cover specific areas of deficit and help define goals of care. This review discusses NCI in the dialysis setting, including developments in the definition of neurocognitive impairment, dialysis-specific epidemiology across modalities, screening strategies and opportunities for dialysis providers in this space.
© 2018 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  cognitive dysfunction; dementia; renal dialysis

Mesh:

Year:  2018        PMID: 29345092     DOI: 10.1111/nep.13223

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  4 in total

Review 1.  [Long-term physical and psychological consequences of chronic kidney disease].

Authors:  Friedrich Thaiss
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2022-03-21       Impact factor: 1.513

Review 2.  Epidemiology of peritoneal dialysis outcomes.

Authors:  Aminu K Bello; Ikechi G Okpechi; Mohamed A Osman; Yeoungjee Cho; Brett Cullis; Htay Htay; Vivekanand Jha; Muhammad A Makusidi; Mignon McCulloch; Nikhil Shah; Marina Wainstein; David W Johnson
Journal:  Nat Rev Nephrol       Date:  2022-09-16       Impact factor: 42.439

3.  Effect of valerian on cognitive disorders and electroencephalography in hemodialysis patients: a randomized, cross over, double-blind clinical trial.

Authors:  Afshin Samaei; Monir Nobahar; Zaynab Hydarinia-Naieni; Abbas Ali Ebrahimian; Mohammad Reza Tammadon; Raheb Ghorbani; Abbas Ali Vafaei
Journal:  BMC Nephrol       Date:  2018-12-27       Impact factor: 2.388

4.  Shared decision-making in advanced kidney disease: a scoping review protocol.

Authors:  Noel Engels; Gretchen de Graav; Paul van der Nat; Marinus van den Dorpel; Willem Jan Bos; Anne M Stiggelbout
Journal:  BMJ Open       Date:  2020-02-27       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.